BRIEF published on 07/11/2025 at 12:35, 4 months 25 days ago Provision of the Letter to Shareholders by WALLIX Shareholders Cybersecurity WALLIX 2025 Turnover IAM And PAM
BRIEF published on 07/07/2025 at 18:35, 4 months 28 days ago Total number of shares and voting rights of WALLIX Voting Rights Financial Markets Authority Actions Turnover WALLIX
BRIEF published on 07/07/2025 at 18:20, 4 months 28 days ago Half-yearly report on the WALLIX liquidity contract as of June 30, 2025 Liquidity Contract Half-yearly Report Financial Markets Stock Transactions WALLIX
BRIEF published on 06/30/2025 at 18:05, 5 months 4 days ago Evolution of the number of shares and voting rights at WALLIX Voting Rights Euronext Actions Cybersecurity WALLIX
BRIEF published on 06/26/2025 at 08:35, 5 months 9 days ago WALLIX Strengthens its Position in Cybersecurity in the Healthcare Sector Identity Management Health Cybersecurity Secure Digital Access Medical Data Protection WALLIX Solutions
PRESS RELEASE published on 06/26/2025 at 08:30, 5 months 9 days ago Cybersecurity and continuity of care: WALLIX consolidates its European leadership in the healthcare sector WALLIX, the European leader in IAM and PAM, provides secure solutions for healthcare cybersecurity challenges, ensuring access control and data protection Access Control Healthcare Cybersecurity WALLIX IAM PAM
BRIEF published on 06/17/2025 at 08:05, 5 months 18 days ago WALLIX: Ten Years of Listing and European Leadership in Cybersecurity Innovation Cybersecurity Euronext Growth Independence PAM And IAM
PRESS RELEASE published on 06/17/2025 at 08:00, 5 months 18 days ago WALLIX, the new European leader in cybersecurity, celebrates ten years of listing on Euronext Growth WALLIX celebrates tenth anniversary on Paris Stock Exchange, transforming into European cybersecurity leader, focusing on digital sovereignty, innovation, and long-term growth Innovation Cybersecurity European Leader Digital Sovereignty WALLIX
BRIEF published on 06/05/2025 at 19:20, 5 months 29 days ago WALLIX launches a share buyback program Capital Share Buyback General Meeting WALLIX Liquidity Effect
BRIEF published on 04/16/2025 at 18:05, 7 months 18 days ago WALLIX publishes its 2024 annual financial report Euronext Cybersecurity Financial Report Financial Publication WALLIX
Published on 12/05/2025 at 14:00, 18 minutes ago Ocean Power Technologies Attending the 3rd Annual DealFlow Discovery Conference
Published on 12/05/2025 at 14:00, 18 minutes ago Bonk, Inc. Highlights Major Ecosystem Milestone: Launch of Regulated BONK ETP on SIX Swiss Exchange
Published on 12/05/2025 at 02:35, 11 hours 43 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 13 hours 18 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/05/2025 at 13:45, 33 minutes ago BingX Introduces Recurring Buy to Help Users Ride Out Crypto Market Swings
Published on 12/05/2025 at 13:00, 1 hour 18 minutes ago Zentra Group plc: Posting of Notice of Annual General Meeting
Published on 12/05/2025 at 13:00, 1 hour 18 minutes ago Form 8.3 - Zürcher Kantonalbank: Cicor Technologies Ltd.
Published on 12/05/2025 at 12:05, 2 hours 13 minutes ago Cango Inc. Announces November 2025 Bitcoin Production and Mining Operations Update
Published on 12/05/2025 at 12:00, 2 hours 18 minutes ago CGTN：Strengthening cultural ties: Peng Liyuan, Brigitte Macron visit Beijing People's Art Theatre
Published on 12/05/2025 at 08:45, 5 hours 33 minutes ago Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
Published on 12/04/2025 at 18:00, 20 hours 18 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 20 hours 33 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 20 hours 34 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 1 day 7 hours ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
